Consistent with previous work39, we also found that prednisolone induces upregulation of IKBα, an inhibitor of NF-κB as the mechanism for inhibiting the canonical pathway for activation of NF-κB in NSCLC cell lines (Fig. 1j, k, p–q). The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.